Acknowledging the kind of traction gained by this market, Industry Data Analytics recently published a study report asserts the global Targeted RNA Sequencing Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 12.2% during the review period (2022 to 2027).
Targeted RNA Sequencing Market Overview
Targeted RNA sequencing is a sequencing-based gene expression profiling method that allows quantification of messenger RNA (mRNA) or targeted non-coding RNA (ncRNA) levels for up to 300 customer-defined genes in a single amplification reaction. Targeted RNAseq is increasingly the method of choice for researchers studying the transcriptome. The clinical potential of RNAs as disease and treatment markers is fueling advances in RNA analysis methods. It offers numerous advantages over gene expression arrays as it is compatible with difficult samples such as formalin-fixed paraffin embedded (FFPE) tissue, requires a low input of 10ng of total RNA or 20 – 100ng of FFPE RNA.It can also be applied to any species, even if reference sequencing is not available. Broader dynamic range enables more sensitive and accurate measurement of gene expression and a better value often delivering advantages at a comparable or lower price per sample than many arrays which are costlier in comparison to these. But as RNA sequencing data accumulates, and researchers compare findings, standardization has become a major issue.
Who are the Major Players in Targeted RNA Sequencing Market?
Top Key players in the Targeted RNA Sequencing Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Targeted RNA Sequencing Market is fragmented with a large number of small players operating worldwide. The companies referred in the market research report includes Thermo Fisher Scientific Inc. (NYSE :TMO), Illumina Inc. (NasdaqGS:ILMN), Roche Holdings AG (Other OTC:RHHBY), Birks Group Inc. (NYSE American:BGI), Eurofins, LabCorp, Berry Genomics Co.,Ltd (Shenzhen :000710.SZ), Macrogen, GENEWIZ and others.
What are the major Applications, Types and Regions for Targeted RNA Sequencing Market?
Targeted RNA Sequencing Market is segmented based on the type, applications, companies and regions.
By Type, Targeted RNA Sequencing Market has been segmented into
- enrichment approaches
- amplicon-based approaches
The end user’s industry application on Targeted RNA Sequencing Market is,
- Research Institutes
- Hospitals & Clinics
- Biotechnology Company
- Diagnostic Lab
Targeted RNA Sequencing Market Regional Analysis:
North America followed by Europe dominates the global targeted RNA sequencing market, due to rising government support towards research and development. Asia is expected to witness high growth targeted RNA sequencing due to rising investment in India and China on research and development.
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
What is our Targeted RNA Sequencing Market report scope?
Report Attributes
|
Report Details
|
Forecast Period 2022 to 2027 CAGR
|
CAGR of 12.2% during the review period (2022 to 2027).
|
By Type
|
- enrichment approaches
- amplicon-based approaches
|
By Application
|
- Research Institutes
- Hospitals & Clinics
- Biotechnology Company
- Diagnostic Lab
|
By Companies
|
Thermo Fisher Scientific Inc. (NYSE :TMO), Illumina Inc. (NasdaqGS:ILMN), Roche Holdings AG (Other OTC:RHHBY), Birks Group Inc. (NYSE American:BGI), Eurofins, LabCorp, Berry Genomics Co.,Ltd (Shenzhen :000710.SZ), Macrogen, GENEWIZ and others.
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
Base Year
|
2022
|
Historical Year
|
2017 to 2021
|
Forecast Year
|
2022 to 2027
|
Number of Pages
|
93
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Key Takeaways from this Targeted RNA Sequencing Market Report
- Evaluate Targeted RNA Sequencing market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
- Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.
- Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
- Analyze the sales and distribution channels across key geographies to improve top-line revenues.
- Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
- Get a quick outlook on the Targeted RNA Sequencing market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
- Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
Frequently Asked Questions
What is the study period of this market?
The Targeted RNA Sequencing Market is studied from 2017 - 2027.
What is the growth rate of Targeted RNA Sequencing Market?
The Targeted RNA Sequencing Market is growing at a CAGR of 12.2% over the next 5 years.
Who are the leading key players in Targeted RNA Sequencing Market?
Thermo Fisher Scientific Inc. (NYSE :TMO), Illumina Inc. (NasdaqGS:ILMN), Roche Holdings AG (Other OTC:RHHBY), Birks Group Inc. (NYSE American:BGI), Eurofins, LabCorp, Berry Genomics Co.,Ltd (Shenzhen :000710.SZ), Macrogen, GENEWIZ and others.
What regions regions does this Targeted RNA Sequencing Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Targeted RNA Sequencing Market?
enrichment approaches, amplicon-based approaches
What are the significant Applications of Targeted RNA Sequencing Market?
Research Institutes, Hospitals & Clinics, Biotechnology Company, Diagnostic Lab
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
